Cargando…

Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients

Chronic lymphocytic leukaemia (CLL) is characterised by a heterogeneous clinical course. Such heterogeneity is associated with a number of markers, including TP53 gene inactivation. While TP53 gene alterations determine resistance to chemotherapy, it is not clear whether they can influence early dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monti, Paola, Lionetti, Marta, De Luca, Giuseppa, Menichini, Paola, Recchia, Anna Grazia, Matis, Serena, Colombo, Monica, Fabris, Sonia, Speciale, Andrea, Barbieri, Marzia, Gentile, Massimo, Zupo, Simonetta, Dono, Mariella, Ibatici, Adalberto, Neri, Antonino, Ferrarini, Manlio, Fais, Franco, Fronza, Gilberto, Cutrona, Giovanna, Morabito, Fortunato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595214/ https://www.ncbi.nlm.nih.gov/pubmed/33116240 http://dx.doi.org/10.1038/s41598-020-75364-3

Ejemplares similares

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study
por: De Luca, Giuseppa, et al.
Publicado: (2022)

Antitumor Effects of PRIMA-1 and PRIMA-1(Met) (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
por: Menichini, Paola, et al.
Publicado: (2021)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
por: Monti, Paola, et al.
Publicado: (2020)

MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells
por: Matis, Serena, et al.
Publicado: (2022)

NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome
por: Ronchetti, Domenica, et al.
Publicado: (2020)

Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements
por: Bagnara, Davide, et al.
Publicado: (2022)

Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukaemia
por: Maura, Francesco, et al.
Publicado: (2015)

LINC00152 expression in normal and Chronic Lymphocytic Leukemia B cells
por: Matis, Serena, et al.
Publicado: (2021)

Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines
por: Giannoni, Paolo, et al.
Publicado: (2020)

A High Percentage of CD16+ Monocytes Correlates with the Extent of Bone Erosion in Chronic Lymphocytic Leukemia Patients: The Impact of Leukemic B Cells in Monocyte Differentiation and Osteoclast Maturation
por: Giannoni, Paolo, et al.
Publicado: (2022)

Mutant p53(K120R) expression enables a partial capacity to modulate metabolism
por: Monti, Paola, et al.
Publicado: (2022)

Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of Chronic Lymphocytic Leukemia
por: Maura, Francesco, et al.
Publicado: (2011)

Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay
por: Monti, Paola, et al.
Publicado: (2021)

Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach
por: Colombo, Monica, et al.
Publicado: (2020)

Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia
por: Ronchetti, Domenica, et al.
Publicado: (2013)

Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia
por: Morabito, Fortunato, et al.
Publicado: (2021)

Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling
por: De Luca, Giuseppa, et al.
Publicado: (2020)

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab
por: Gentile, Massimo, et al.
Publicado: (2020)

TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear
por: Monti, Paola, et al.
Publicado: (2017)

Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients
por: Dono, Mariella, et al.
Publicado: (2019)

Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells
por: De Cecco, Loris, et al.
Publicado: (2015)

Heterogeneous expression of the collagen receptor DDR1 in chronic lymphocytic leukaemia and correlation with progression
por: Barisione, G, et al.
Publicado: (2017)

Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
por: Marengo, Barbara, et al.
Publicado: (2018)

Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia
por: Bagnara, Davide, et al.
Publicado: (2022)

Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy
por: Morabito, Fortunato, et al.
Publicado: (2023)

ΔN-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites
por: Monti, Paola, et al.
Publicado: (2014)

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies
por: Agathangelidis, Andreas, et al.
Publicado: (2023)

Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival
por: Foggetti, Giorgia, et al.
Publicado: (2019)

Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2021)

lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome
por: Ronchetti, D, et al.
Publicado: (2016)

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
por: Cuneo, Antonio, et al.
Publicado: (2020)

p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System
por: Andreotti, Virginia, et al.
Publicado: (2011)

The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
por: Van Dyke, Daniel L., et al.
Publicado: (2016)

P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development
por: Monti, Paola, et al.
Publicado: (2019)

BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer
por: Monti, Eleonora, et al.
Publicado: (2015)

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)

Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients
por: Ravera, Silvia, et al.
Publicado: (2020)

Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
por: Ciribilli, Yari, et al.
Publicado: (2013)

Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function
por: Manzini, Claudia, et al.
Publicado: (2016)

CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL
por: Cutrona, G, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_sjqpvebstskuuhgilldbsvul4m